Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 Mar 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Jul 16;18(3):676–683.e3. doi: 10.1016/j.cgh.2019.07.017

Figure 5: — Subgroup analysis after removing cystic lesions from control group and IPMN-HGD from case group A. AUCs of 4-MDM panel, best-fit and cross-validation. B. Sensitivity and specificity of the 4-MDM panel across all stages and when stratified by early or late stage PDAC.

Figure 5: — Subgroup analysis after removing cystic lesions from control group and IPMN-HGD from case group A. AUCs of 4-MDM panel, best-fit and cross-validation. B. Sensitivity and specificity of the 4-MDM panel across all stages and when stratified by early or late stage PDAC.